INmune Bio
INMB
INMB
40 hedge funds and large institutions have $37.7M invested in INmune Bio in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 7 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
2% less funds holding
Funds holding: 41 → 40 (-1)
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
Holders
40
Holding in Top 10
1
Calls
$2.84M
Puts
$2.79M
Top Buyers
| 1 | +$5.34M | |
| 2 | +$2.4M | |
| 3 | +$1.35M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$1.26M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.16M |
Top Sellers
| 1 | -$2.84M | |
| 2 | -$2.33M | |
| 3 | -$2.05M | |
| 4 |
ACM
Altium Capital Management
New York
|
-$918K |
| 5 |
BlackRock
New York
|
-$730K |